Just over two years into its five-year effort to fundamentally transform its R&D activities, Takeda Pharmaceutical Co. Ltd. says the initiative has led to a more focused approach and an enlarged pipeline, fueled by an open approach to partnering.
Takeda To Press On With Core R&D Strategy Post-Shire
Takeda continues to pursue the transformation of its R&D activities, which has already led to expansion of the pipeline, but will continue with core strategies including partnering even after the huge Shire acquisition.
